-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.ISIN US09075V1026-
BioNTechBörse Börse FrankfurtWKNSymbol 22UA
-
BioNTechBörse Xetra FrankfurtSymbol 22UA
-
BioNTech SE - ADRBörse Börse BerlinSymbol 22UA
-
BioNTech SE - ADRBörse Börse MünchenSymbol 22UA
-
BIONTECH SE-ADRBörse Börse StuttgartSymbol 22UA
-
BIONTECH SE-ADRBörse Tradegate System der Deutsche Börse AG (60%)Symbol 22UA
-
BIONTECH SE-ADRBörse Börse HamburgSymbol 22UA
-
BIONTECH SE-ADRBörse Quotrix System der Börse DüsseldorfSymbol 22UA
-
BIONTECH SE-ADRBörse Börse DüsseldorfSymbol 22UA
-
BIONTECH SE-ADRBörse Gettex System der Börse MünchenSymbol 22UA
-
ISIN US09075V1026 WKN: A2PSR2Symbol BNTX
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US09075V1026
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
BioNTech SEBörse London Stock Exchange
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.800 oder 4.530 Mitarbeiter
BioNTech outperformed den DAX um +966 % vom 10.10.2019 bis 02.09.2022
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 299,9 EUR +1,45%
Letzte Communitymeinungen
- 5 User waren zuletzt bullisch
- Im Beta-Tester Jahresendrally Battle 2021
-
SaLyn
14.09.2021
-
Karamellsaus_55
29.08.2021
-
Zockrat
29.08.2021
Ein User hat BioNTech abonniert.
Aktionärsstruktur der BioNTech SE
Portrait der BioNTech Aktie
Das Unternehmen BioNTech SE aus Deutschland beschäftigt 3.165 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Die BioNTech Aktie konnte seit dem 10.10.2019 eine Rendite von sage und schreibe 970% erwirtschaften und mit dieser Performance den deutschen Leitindex DAX um 966% outperformed, der im gleichen Zeitraum 4% erwirtschaften konnte.
Mit einem Streubesitz von lediglich 19,7% ist der free float der Aktie vergleichsweise gering. Ein genauerer Blick in die Aktionärsstruktur könnte nützlich sein um den geringen Streubesitz vielleicht aufzuklären.
Das Unternehmen BioNTech SE ist nur in 5 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet BioNTech mit 6,85% im ETF.
5 ETFs die in BioNTech investieren
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
356 News & Informationen zur BioNTech Aktie
Pfizer to seek U.S. authorization for COVID booster shot as Delta variant spreads
NEW YORK — Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker’s top scientist…
Pfizer to ask FDA to authorize booster dose of Covid vaccine as Delta variant spreads
Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker's top scientist said on Thursday, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant. Pfizer Chief Scientific Officer Mikael Dolsten said the recently reported dip in the vaccine's effectiveness in Israel was mostly due to infections in people who had been vaccinated in January or February. The country's health ministry said vaccine effectiveness in preventing both infection and symptomatic disease fell to 64% in June.
Pfizer to Ask Regulators to Authorize Covid-19 Vaccine Booster
Pfizer and partner BioNTech are also developing an updated version of their vaccine that would better target the Delta variant.
Delta variant set to dominate Covid strain in under-vaccinated hot spots in US
A study by top international scientists concludes that animal contagion is the most likely explanation for the pandemic’s genesis
New daily COVID-19 cases and deaths spike to 6-week highs as delta variant spreads rapidly
New daily COVID-19 cases and deaths jumped to six-week highs, as the delta variant has continued to spread rapidly to become the dominant strain in the U.S.
Ocugen, Welbilt rise; Talos Energy, Hess fall
Stocks that traded heavily or had substantial price changes Tuesday:
Dr. Fauci advises vaccinated Americans to wear masks in areas with low COVID-19 immunization rates
'You might want to go the extra step,' said Anthony Fauci, President Joe Biden’s chief medical adviser.
Israel, South Korea to Swap 700,000 Pfizer-BioNTech Covid-19 Vaccines
Israel is sending the soon-to-expire shots to South Korea this week after a deal with the Palestinian Authority fell through.
Do Hedge Funds Love CBRE Group, Inc. (CBRE)?
Is CBRE Group, Inc. (NYSE:CBRE) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by…
Delta variant brings calamity to countries stuck waiting for covid-19 vaccines
Sparsely vaccinated developing countries have been left exposed while shots protect wealthy nations from surges in hospitalizations and deaths
Israel sees steep drop in Pfizer vaccine efficacy rate: Report
Read more about Israel sees steep drop in Pfizer vaccine efficacy rate: Report on Business Standard. At the same time, protection against hospitalisation and serious illness remained strong
Israel sees decline in Pfizer covid vaccine efficacy rate, says report
The decline in protection against serious cases and hospitalization is considerably milder, the website said
BioNTech (BNTX) is Off to a Great Start in 2021
BioNTech SE (NASDAQ:BNTX) has been around for nearly 13 years now. It was founded by two scientists named Ugur Sahin and Özlem Türeci with the vision…
Australia Plots Covid-19 Exit Strategy
Trying out shorter quarantine periods for some vaccinated travelers and the gradual return of foreign students are part of a four-stage plan to return life to normal.
EMEA Morning Briefing : Stocks to Rise After S&P -2-
Around 50 Jewish families built trailer-sized homes of concrete blocks and metal-sheet roofs on the hilltop outpost in Evyatar starting in May, sparking daily protests by local Palestinians who…
White House prepares for COVID-19 outbreaks due to highly contagious Delta variant By Reuters
White House prepares for COVID-19 outbreaks due to highly contagious Delta variant
Is BioNTech SE Sponsored (BNTX) Outperforming Other Medical Stocks This Year?
Is (BNTX) Outperforming Other Medical Stocks This Year?
Heart inflammation after COVID-19 shots higher-than-expected in study of U.S. military By Reuters
Heart inflammation after COVID-19 shots higher-than-expected in study of U.S. military
Sanofi bets on mRNA vaccines after covid-19 pandemic shows worth
One of the world’s biggest vaccine makers, it plans to invest some $477 million a year to catch up in the new gene-based technology
Biontech SE: Game Changer Award 2021 für Özlem Türeci und Uğur Şahin
Dem Mainzer Biotechunternehmen gelang mit dem Impfstoff gegen Covid-19 ein überragender Erfolg. Vor allem aber schufen die Gründer mit der mRNA-Technologie die Grundlage für eine neue Klasse von hocheffizienten Medikamenten.
Primecap Odyssey Funds' 2021 Semiannual Letter to Shareholders
GuruFocus Article or News written by Sydnee Gatewood and the topic is about: Discussion of markets and holdings
Is Weyerhaeuser Co. (WY) A Good Stock To Buy?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge…
Make-a-Wish to grant fully vaccinated children wishes involving air travel, large gatherings in September
Make-A-Wish America president and CEO Richard Davis announced that the foundation will resume granting wishes involving large gatherings and air travel within the United States and federal territories for fully vaccinated children and their families beginning September 15.
Global tally of COVID cases top 180 million as fast-spreading delta variant continues to alarm experts
The global tally of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 180 million on Friday and the death toll moved closer to 4…
Vaccinated People Account for Half of New Covid-19 Delta Cases in Israeli Outbreak
Preliminary findings by Israeli health officials prompted the government to reimpose an indoor mask requirement and other measures to contain the highly transmissible strain of Covid-19.
Redmile Group, LLC Buys Jazz Pharmaceuticals PLC, Seagen Inc, Medtronic PLC, Sells AbbVie Inc, Gilead Sciences Inc, 1Life Healthcare Inc
GuruFocus Article or News written by insider and the topic is about:
The 20 best-performing IPOs of the past three years have returned up to 1,477%
These stock-market winners include BioNTech, Zoom, CrowdStrike and Nio.
Brazil and Russia see fresh wave of COVID cases, showing pandemic is far from over in many places
Brazil counted a record number of new cases of COVID-19 on Thursday, while Russia saw its highest tally since late January, highlighting the unequal state of…
Illicit covid-19 drugs bound for Mexico seized by US authorities
Possibly counterfeit or generic versions of Gilead’s remdesivir are reaching U.S. via airports
Illicit COVID-19 drugs bound for Mexico seized by US authorities
Criminal activity is on the uprise in U.S. airports, where federal authorities continue to seize illegal COVID-19 drugs trying to make their way to Mexico.
Delta variant of SARS-CoV-2 is now in 85 countries and accounts for 20% of U.S. infections in past two weeks
The delta variant of COVID-19 has now been detected in 85 countries, according to the World Health Organization, and remains a variant of concern with…
Global Coronavirus Vaccine Market to Surpass US$ 95,988.0 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, June 23, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global coronavirus vaccine market is estimated to be valued at US$…
Illicit Covid-19 Drugs Bound for Mexico Seized by U.S. Authorities
Counterfeit or generic versions of remdesivir, an antiviral manufactured by Gilead Sciences, are arriving in the U.S. by plane from Bangladesh and India and being smuggled by individuals to Mexico.
4 Trending Health Care Stocks To Watch Right Now
Could these health care stocks maintain their growth momentum?
Saying ‘no’ to covid-19 vaccine in Pakistan carries consequences
Authorities threaten the unimmunized with penalties including cellphone cutoffs and salary suspensions
WHO warns poorer countries are not getting fair share of COVID vaccine supply, as Colombia passes 100,000 deaths
The global tally of confirmed cases of COVID-19 was headed toward 179 million on Tuesday, a day after the World Health Organization issued its latest warning…
China to keep covid-19 border restrictions for another year
Beijing worries about variants as it stages the Olympics and a power transition
China to Keep Covid-19 Border Restrictions for Another Year
Beijing is concerned about variants as it stages the Olympics and a power transition, people familiar with the matter say.